| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10593524 | Bioorganic & Medicinal Chemistry Letters | 2013 | 9 Pages |
Abstract
Multiple approaches have led to the identification of potent inhibitors of Pin1, a peptidyl prolyl isomerase implicated in tumourigenesis. Here we discuss the modes of action and likely specificity of these compounds and the prospects for identification of improved inhibitors in the future.
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Jonathan D. Moore, Andrew Potter,